AstraZeneca Announces The Launch Of A Catalyst Network Hub In Africa
AstraZeneca Announces The Launch Of A Catalyst Network Hub In Africa. Pharmaceutical Manufacturing company based in Cambridge AstraZeneca has announced the launch of its Catalyst Network Hub In South Africa. Ruth Field, Director at AstraZeneca took to LinkedIn to make the announcement.
The post read, “We have now launched our new A Catalyst Network hub in Africa. The news was officially announced this week as we signed a new partnership with MedSol AI Solutions at the Daspoort Poli Clinic in Pretoria.The new hub forms part of our ongoing commitment to improving health access and creating sustainable healthcare across Africa. Its work will centre on disease education, early diagnosis, technology and data generation, and projects that could enhance diagnosis and improve patient quality of life have already begun.”
AstraZeneca is a global, science-led, patient-focused pharmaceutical company. The company is dedicated to transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. It is focused on creating genuinely innovative medicines and improving access to them. In this way, the company delivers the greatest benefit to patients, healthcare systems and societies globally.
The post continued to say, “The hub sees us leveraging our preexisting partnership with Tricog Health to drive the early diagnosis and treatment of heart failure in Kenya, using Tricog’s InstaECG AI tools. Meanwhile in South Africa, we are collaborating with MedSol AI Solutions to develop Melusi Breast AI, a state-of-the-art ultrasound probe for breast cancer detection.I’m proud to be leading AstraZeneca’s efforts to develop cutting-edge solutions with the potential to pave the way for the future of patient-centric digital healthcare.”
